Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Lab literacy

What Is Bacteriostatic Water? Reconstitution Diluents Explained

A clear educational explainer on bacteriostatic water, sterile water, and how diluents are used to reconstitute lyophilized peptides in the lab—plus why the terminology matters. Not medical advice.

By The Peptides Codex Editorial TeamIndividual review date not recorded

What bacteriostatic water is

Bacteriostatic water is sterile water for injection that contains a small amount of a preservative—most commonly 0.9% benzyl alcohol—that inhibits the growth of bacteria. The preservative is what allows a sealed multi-dose vial to be entered more than once over a limited period without supporting microbial growth. This is a general educational explainer about a common laboratory diluent, not instructions for preparing anything for human use.

Bacteriostatic vs sterile vs 'water for injection'

The terms are not interchangeable. Sterile water for injection contains no preservative and is generally intended for single use. 'Bacteriostatic' specifically means a preservative is present to inhibit bacterial growth—not that the water is somehow more sterile. Understanding this distinction is basic lab literacy: the words describe preservative content and intended reuse, not a quality ranking.

Why lyophilized peptides need a diluent at all

Many research peptides ship as a lyophilized (freeze-dried) powder because they are more stable dry than in solution. To study them in solution, that powder is reconstituted by adding a diluent. The choice of diluent—and its preservative content—affects handling and short-term stability of the resulting solution, which is why the topic comes up constantly alongside reconstitution.

Preservative compatibility considerations

In the literature, benzyl-alcohol-containing diluents are noted as generally compatible with many peptides, but not universally—some sensitive molecules or specific formulations call for preservative-free water. This is a real analytical consideration rather than a trivial one, and it is one reason product documentation and a certificate of analysis matter when handling research materials.

Storage and terminology pitfalls

Reconstituted solutions generally need refrigeration and have a shorter usable life than the dry powder—covered in our storage and stability and half-life guides. A frequent terminology pitfall is assuming 'bacteriostatic' implies safety for human injection; it does not. The preservative addresses microbial growth in the vial, not the regulatory status or human-use safety of whatever is dissolved in it.

Regulatory and safety framing

Describing a diluent is not the same as endorsing preparation of any compound for human use. Many research peptides are not authorized by Health Canada for human use, and this guide does not provide preparation protocols, doses, or injection instructions. It exists to explain terminology that is widely misunderstood.

Sources and what they cover

These primary studies, official records and standards cover the topics linked below. The scope notes distinguish laboratory findings, human trials and regulatory records. This is a selected bibliography, not a systematic review or verification of every sentence; absence of a study here does not prove that no study exists.

  1. DailyMed — Bacteriostatic Water for Injection, USP prescribing label

    Product-specific composition, warnings and compatibility requirements. It does not authorize reconstitution of unapproved compounds.

    Relevant sections: What bacteriostatic water is · Bacteriostatic vs sterile vs 'water for injection' · Preservative compatibility considerations · Storage and terminology pitfalls

  2. Health Canada (2026) — unauthorized injectable peptides bought online

    Canadian safety and authorization notice for the products described. It does not establish approval status in every country.

    Relevant sections: Regulatory and safety framing

FAQ

What is bacteriostatic water used for?+

It is sterile water containing a preservative (commonly 0.9% benzyl alcohol) that inhibits bacterial growth, allowing a sealed multi-dose vial to be used more than once over a limited period. In labs it is a common diluent for reconstituting lyophilized peptides. This is educational information, not preparation instructions.

What is the difference between bacteriostatic and sterile water?+

Sterile water for injection has no preservative and is generally single-use. Bacteriostatic water contains a preservative to inhibit bacterial growth. The difference is preservative content and intended reuse—not a ranking of how 'sterile' the water is.

Does bacteriostatic water make a peptide safe to inject?+

No. The preservative addresses microbial growth in the vial only. It says nothing about the regulatory status or human-use safety of whatever is dissolved in it. Many research peptides are not authorized by Health Canada for human use.

Why do some peptides need preservative-free water?+

Some sensitive molecules or formulations are noted in the literature as less compatible with benzyl-alcohol diluents, so preservative-free sterile water is used instead. Product documentation and a COA help clarify compatibility.

Related peptide profiles

BPC-157
Research pentadecapeptide (gastric-juice-derived sequence)
BPC-157 (Body Protection Compound-157) is a synthetic 15-residue peptide, GEPPPGKPADDAGLV, derived from a sequence found in human gastric juice. Hundreds of rodent studies, most from a single Zagreb group, report accelerated healing of tendon, muscle, ligament, gut and skin injuries via VEGFR2, nitric-oxide and ERK1/2 pathways. Human evidence is limited to a small safety study and a retrospective chart review; the first phase 2 efficacy trial began recruiting in 2026. It is not approved anywhere and the FDA barred it from compounding in 2023.
Semaglutide
Incretin analog
Semaglutide is a 31-amino-acid GLP-1 receptor agonist peptide (C187H291N45O59, ≈4,114 Da). It keeps 94% of the human GLP-1 sequence but substitutes Aib at position 8 to block DPP-4 cleavage, replaces Lys34 with Arg, and attaches a C18 fatty diacid to Lys26 through a γ-glutamate and two OEG spacers so the peptide binds albumin. The result is a half-life of about 7 days and once-weekly dosing in the approved products Ozempic and Wegovy (and once-daily oral dosing as Rybelsus).
CJC-1295
Long-acting GHRH analogue (research compound)
CJC-1295 (C165H269N47O46, ≈3,647 Da) is a 30-residue analogue of growth hormone-releasing hormone(1-29) engineered by ConjuChem to bind serum albumin covalently after injection, extending its action from minutes to days. In healthy adults a single injection raised growth hormone 2- to 10-fold for six days or more and IGF-1 1.5- to 3-fold for 9–11 days, with an estimated half-life of 5.8–8.1 days. It was never approved: a phase 2 trial in HIV-associated visceral obesity was terminated, and it is now an unapproved research peptide prohibited in sport.

More guides

Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Regulations vary by jurisdiction.
You might also like: All guides · Encyclopedia · Tools · FAQ
Cite this: Peptides Codex — What Is Bacteriostatic Water? Reconstitution Diluents Explained
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.